'Chips and Science Act' Expected To Accelerate More UVA Startups

LVG Executive Director Richard Chylla and Entrepreneur in Residence Andy Krouse Visited With U.S. Treasury Secretary Janet Yellen and Senator Tim Kaine.

lvg.virginia.edu

PitchBook-Certified: UVA Recognized For Producing Future Entrepreneurs • UVA Licensing & Ventures Group

Platform ranks colleges by its startup founders.

lvg.virginia.edu

LVG Inventor Becomes First Faculty Member to Win Moore Inventor Fellowship

lvg.virginia.edu

UVA Joins $15 Million NSF-Funded Innovation Hub

New research consortium's goal is to accelerate the translation of discoveries into solutions that benefit society.

lvg.virginia.edu

Licensing Team Members Share Experiences From ‘Women Building Bio’ Conference

lvg.virginia.edu

Paid LVG Internships Begin With Free Workshops

lvg.virginia.edu

Renowned Researcher, Entrepreneur and Engineering Dean Joins LVG Board

University of Virginia School of Engineering and Applied Science Dean Jennifer L. West is the newest member of the Licensing & Ventures Group’s Board of Directors.

lvg.virginia.edu

HIV Care Platform Licensed by WHT Lauded as 'Best Care Practice' by Health Department

PositiveLinks now available worldwide through PL Cares

lvg.virginia.edu

Eyes in the Sky: Astraea has Techies, Business Leaders, Environmentalists & Investors Chomping at the Bit

The geospatial analytics startup was oversubscribed in its recent investment round.

lvg.virginia.edu

In Memoriam: Professor Mark Kester was 'Prolific' Innovator and Renowned Nanotechnologies Expert

Mark Kester submitted more than 20 invention disclosures

lvg.virginia.edu

Summer Newsletter

LVG News

lvg.virginia.edu

Getting to Know You: How Bio Convention Lays Foundation For Future Deals

lvg.virginia.edu

LVG Partner Bryan Berger Talks Food Safety With NBC29

www.nbc29.com

'Missing Link' AgroSpheres Announces Novel Modalities Partnership With Bayer

Technology Will Take Crop Protection Products to New Level

lvg.virginia.edu

Lytos Founder Takes Aim at 'Dirty Dozen'

Strawberries and spinach top the list of fruits and vegetables with the most pesticides

news.virginia.edu

LVG's Second Seed Fund is Off and Running

lvg.virginia.edu

With the Help of LVG, This Professor is Making Fruits and Vegetables Safer to Eat

Bryan Berger is creating green, sustainable and safer alternatives to farming pesticides and disinfectants

lvg.virginia.edu

Chemistry Students Learn Finer Points of Tech Transfer Through LVG Internships

Rachelle Turiello, left, and Renna Nouwairi, right, say their experience as LVG interns has been the perfect complement to their work in the chemistry lab.

lvg.virginia.edu

Fly Me to the Moon: New Licensing & Ventures Leader Has Big Goals

Five questions for Richard Chylla, the UVA Licensing & Ventures Group’s new executive director.

news.virginia.edu

Richard Chylla Named Executive Director

Richard Chylla, Ph.D., Executive Director of Michigan State University Technologies, has been named Executive Director of the University of Virginia Licensing & Ventures Group (UVA LVG) effective January 24, 2022.

lvg.virginia.edu

MRI Pioneer Craig Meyer Elected to National Academy of Inventors

Meyer, a professor of biomedical engineering, radiology and medical imaging, joins the list of the nation’s top innovators for his contributions to MRI technology and imaging.

news.virginia.edu

FDA Approves Focused Ultrasound for Common Parkinson’s Symptoms

The pioneering UVA research provides new options for Parkinson’s patients.

news.virginia.edu

Innovator of the Year Made Herculean Efforts Throughout the Pandemic

The UVA Licensing & Ventures Group has named Amy Mathers – who created several responses to meet COVID testing needs throughout the pandemic – the 2021 Edlich-Henderson Innovator of the Year.

news.virginia.edu

2021 Innovator of the Year Honored for Leading COVID-19 Testing Efforts Across Virginia

Honoring Amy J. Mathers, M.D.

lvg.virginia.edu

GenEp Raises $1.45 Million Seed Financing

The latest LVG Seed Fund investment launched GenEp, Inc., a pre-clinical stage biotechnology company developing therapies that address unmet needs in patients with #epilepsy based on University of Virginia research...

www.accesswire.com

Epilepsy Research Reveals Previously Unknown Trigger for Seizures

UVA scientists have identified how failure in the brain’s natural braking system contributes to epileptic seizures.

news.virginia.edu

UVA Licensing & Ventures Group Podcast

On this UVA Speaks podcast, Joshua Mauldin and Matthew Rannals of the UVA Licensing & Ventures Group (LVG) explain the work done by the technology transfer office. Listen in to hear how the group...

soundcloud.com

BASF Adopts BrightSpec's Broadband MRR Technology for Structural Elucidation

BrightSpec announced today the start of operation of a broadband Molecular Rotational Resonance spectrometer at BASF's research center in...

www.prnewswire.com

Shaping the Future of UVA Research Through ‘Grand Challenge’ Investments

University leadership has committed between $20 million and $50 million for research in environmental resilience and neuroscience this academic year. Leaders are seeking research ideas that will “move the needle” in addressing global challenges.

news.virginia.edu

Q&A: Bill Petri on Current Research, Findings, Potential Effects of New Delta Variant

As the new Delta variant circulates around the globe, we checked in with infectious disease expert Dr. Bill Petri for answers on increased transmissibility, booster shot timelines and variant research at UVA.

news.virginia.edu

Brain Discovery Could Lead to New Epilepsy Treatments

Cutting-edge brain research at the University of Virginia has yielded a discovery that could lead to new treatments for epilepsy.

newsroom.uvahealth.com

Governor Northam Announces $3.4 Million to Advance Research Commercialization in Key Technology Sectors

Governor Ralph Northam today announced that 34 small technology-focused businesses in Virginia will receive a total of $3.4 million in Commonwealth Commercialization Fund (CCF) grants to commercialize research...

www.governor.virginia.gov

iTHRIV Seeks Proposals for 2 NIH-Funded Grant Programs

Applications are welcome from Virginia-based non-profits, scientists and clinical professionals from any iTHRIV institution.

newsroom.uvahealth.com

Epilepsy Discovery Reveals Why Some Seizures Prove Deadly

UVA researchers have identified a potential way to prevent sudden unexpected death in epilepsy.

news.virginia.edu

UVA Engineering Link Lab and Leidos Join Forces on Cyber-Physical System Evolution and Expansion

The University of Virginia School of Engineering announced an extension of the partnership between Leidos and the Link Lab, UVA Engineering’s 17,000-square-foot cyber-physical systems research...

engineering.virginia.edu

A Proclamation on World Intellectual Property Day, 2021 | The White House

This year, on World Intellectual Property Day, we celebrate the innovators and creators who enrich our lives and create the...

www.whitehouse.gov

Ceres Receives $8.2M NIH Award to Improve Wastewater-Based COVID-19 Testing

Ceres Nanosciences is announcing today that it has been awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative for $8.2 million to support the implementation of wastewater-based surveillance systems for COVID-19 powered by the Nanotrap particles.

www.ceresnano.com

Cancer Discovery Could Revive Failed Treatments for Solid Tumors

UVA researchers discover why a once-promising approach to treating ovarian, colon and triple-negative breast cancers proved ineffective.

news.virginia.edu

Scientists Urge Swift Action to Prepare for Next Pandemic

The international team, led by a UVA School of Medicine professor, outlined a strategy to facilitate the creation of medications, vaccines and treatments.

news.virginia.edu

UVA Scientist Developing Gene Therapy to Help Girls With Rett Syndrome

The genetic disorder can impair children’s ability to speak, move, and even breathe.

news.virginia.edu

Ceres Nanosciences, Inc. to Increase Manufacturing Capacity for COVID-19 Testing Reagents with Prince William County Expansion

Governor Ralph Northam today announced that Ceres Nanosciences, Inc., a life sciences company that makes innovative products to improve diagnostic testing, will expand its operation in Prince William County’s Innovation Park to increase the manufacturing capacity of its Nanotrap® Magnetic Virus Particles for COVID-19 tests.

www.vedp.org

Cancer Find Up for Year’s Biggest Biomedical Advance in a Different ‘March Madness’

It’s March, which means it’s time for STAT Madness – the tournament for the year’s biggest biomedical innovation. For the third consecutive year, a UVA discovery is among the contenders.

news.virginia.edu

Sounding Out the Future of Focused Ultrasound

UVA's Dr. Jeffrey Elias, who pioneered the use of high-intensity soundwaves to treat tremor and Parkinson’s disease, has now set his sights on erasing chronic pain.

news.virginia.edu

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap Particle Manufacturing Capacity for COVID-19 Testing

www.ceresnano.com

Two UVA Scientists Named to National Academy of Inventors

Robin A. Felder, an expert and innovator in both robotics and human biochemistry, and Boris Kovatchev, pioneer of an artificial pancreas system, become UVA’s eighth and ninth fellows.

news.virginia.edu

Life-Changing Artificial Pancreas Helps Manage Type 1 Diabetes

AUTM's Better World Project seeks to highlight successful examples of technology transfer, demonstrating its importance and positive impact on the world.

autm.net

CIT announces $7M grant funding round - Virginia Business

The Herndon-based Center for Innovative Technology (CIT) on Thursday opened the application process for $7 million in grant funds from its new Commonwealth Commercialization Fund, focused on promoting innovation and technology commercialization initiatives.

www.virginiabusiness.com

Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies

Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Capital led the investment round with participation...

www.prnewswire.com